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Index of suspicion or clinical
awareness?
To the Editor:
I enjoyed reading the article “Lobar torsion
after pulmonary resection: Presentation and
outcome,” by Cable and colleagues (J Tho-
rac Cardiovasc Surg. 2001;122:1091-3).
However, I object to the expression “high
index of suspicion” used in the “Conclu-
sions” section of the abstract.
This is a stereotyped expression, a cli-
che´. Instead of writing about “acute clinical
awareness” or “high level of suspicion,”
both of which are linguistically correct and
have precise meaning, authors of many ar-
ticles and books expose us all too often to
some meaningless “index.” What is an in-
dex? Of several available definitions, I
have chosen two:
1. Index is a number associated with
another number to indicate a math-
ematical operation.
2. Index is a ratio derived from a se-
ries of observations and used as an
indicator of measure.
In both definitions “index” is a number
with certain meaning. Can acute clinical
awareness or high level of suspicion be ex-
pressed in a number? Can a number indicate
how suspicious we are? How high is a “high
index of suspicion?” Is it 10? Is it 100?
Scientific journals should use correct
and precise language, and a good starting
point for editors would be to dispose of
meaningless “indexes.”
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The Thoracic Surgery Foundation for Research and Education
The Thoracic Surgery Foundation for Research and Education extends holiday wishes to its colleagues and
sends its sincerest appreciation to its many donors. Through gifts from many of you, our profession has been
enhanced. Because of your generosity, the TSFRE is succeeding in it mission to support the research careers of
promising young surgeons and surgeon-scientists and to educate cardiothoracic surgeons in health care policy and
programs.
Through the efforts of dedicated physician-volunteers, the TSFRE has partnered with the National Institutes of
Health, National Heart, Lung, and Blood Institute to develop the TSFRE/NHLBI Jointly Sponsored Mentored
Clinical Scientist Development Award (K08). Supported by the TSFRE, the NHLBI, The William J. von Liebig
Foundation, and Datascope, the first ever awardee, Michael Mulligan, MD, of The University of Washington, will
receive more than $750,000 in research support over five years for his promising work: Calcineurin in Lung
Reperfusion Injury. In addition, the TSFRE funded eight annual research and education awards.
This is the season for giving. By making your donation to the TSFRE by year’s end, you will gain several tax
advantages. Donations to charitable organizations, such as TSFRE, are tax deductible. However, these gifts must
be made during the calendar year for which you seek the deduction. Thus, to receive a deduction for the 2002 tax
year, TSFRE must receive your gift by December 31. Gifts of securities, such as stocks that have gained in value,
can provide a special, dual tax advantage. Not only does the donor receive a deduction for the full value of the
security, but the donor also avoids a capital gains tax on the appreciation. Depreciated stock should first be sold
with a resultant cash gift to TSFRE for optimal individual tax advantages. In making gifts of securities, please
consult with your financial advisor about the tax advantages and future value of the security interest.
The TSFRE is pleased to announce that Robin Lynn Hoyle, JD, has been named executive director and that the
management offices have moved to 13 Elm Street, Manchester, MA 01944. If you wish to make a year-end
donation to the TSFRE, feel free to contact Ms Hoyle at 978-526-8330 or at robin@prri.com.
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